SI-BONE, Inc. (SIBN)
15.37
-0.16
(-1.03%)
USD |
NASDAQ |
Jun 10, 16:00
15.37
0.00 (0.00%)
After-Hours: 20:00
SI-BONE Enterprise Value : 584.71M for June 9, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| June 09, 2026 | 584.71M |
| June 08, 2026 | 559.96M |
| June 05, 2026 | 566.59M |
| June 04, 2026 | 555.98M |
| June 03, 2026 | 513.55M |
| June 02, 2026 | 517.53M |
| June 01, 2026 | 511.34M |
| May 29, 2026 | 521.51M |
| May 28, 2026 | 535.21M |
| May 27, 2026 | 539.55M |
| May 26, 2026 | 548.87M |
| May 22, 2026 | 549.31M |
| May 21, 2026 | 555.08M |
| May 20, 2026 | 555.52M |
| May 19, 2026 | 556.41M |
| May 18, 2026 | 552.86M |
| May 15, 2026 | 526.25M |
| May 14, 2026 | 545.76M |
| May 13, 2026 | 526.25M |
| May 12, 2026 | 514.72M |
| May 11, 2026 | 413.16M |
| May 08, 2026 | 442.43M |
| May 07, 2026 | 472.59M |
| May 06, 2026 | 474.36M |
| May 05, 2026 | 497.77M |
| Date | Value |
|---|---|
| May 04, 2026 | 488.92M |
| May 01, 2026 | 482.72M |
| April 30, 2026 | 446.44M |
| April 29, 2026 | 426.09M |
| April 28, 2026 | 445.12M |
| April 27, 2026 | 480.07M |
| April 24, 2026 | 496.44M |
| April 23, 2026 | 491.13M |
| April 22, 2026 | 511.92M |
| April 21, 2026 | 509.71M |
| April 20, 2026 | 531.83M |
| April 17, 2026 | 521.66M |
| April 16, 2026 | 503.08M |
| April 15, 2026 | 539.36M |
| April 14, 2026 | 536.70M |
| April 13, 2026 | 517.68M |
| April 10, 2026 | 466.35M |
| April 09, 2026 | 503.96M |
| April 08, 2026 | 514.58M |
| April 07, 2026 | 480.95M |
| April 06, 2026 | 482.72M |
| April 02, 2026 | 478.19M |
| April 01, 2026 | 473.33M |
| March 31, 2026 | 456.53M |
| March 30, 2026 | 431.21M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Abbott Laboratories | 186.33B |
| AngioDynamics, Inc. | 487.94M |
| Alphatec Holdings, Inc. | 1.742B |
| AtriCure, Inc. | 1.311B |
| Baxter International, Inc. | 17.99B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -4.334M |
| Revenue (Quarterly) | 52.59M |
| Total Expenses (Quarterly) | 56.92M |
| EPS Diluted (Quarterly) | -0.0986 |
| Gross Profit Margin (Quarterly) | 79.76% |
| Profit Margin (Quarterly) | -8.24% |
| Earnings Yield | -2.51% |
| Normalized Earnings Yield | -2.511 |